Filing Details
- Accession Number:
- 0000711377-10-000018
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-10-04 19:36:15
- Reporting Period:
- 2010-10-01
- Filing Date:
- 2010-10-04
- Accepted Time:
- 2010-10-04 19:36:15
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
711377 | Neogen Corp | NEOG | In Vitro & In Vivo Diagnostic Substances (2835) | 382367843 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1168789 | L James Herbert | Neogen Corp 620 Lesher Place Lansing MI 48912 | Chairman & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2010-10-01 | 6,415 | $6.75 | 819,812 | No | 4 | M | Direct | |
Common Stock | Disposition | 2010-10-01 | 6,415 | $32.96 | 813,397 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock Options | Common Stock Option (Right to buy) | Disposition | 2010-10-01 | 6,415 | $0.00 | 6,415 | $6.75 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
134,792 | 2013-10-10 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 194,320 | Indirect | See Note #1 |
Footnotes
- Shares held in trust for the benifit of Mr. Herbert's wife Judith Herbert
- The options were granted as NQ options on 10/10/03 and became exercisable 33% yearly thereafter.